E-Bulletin
November 16, 2023

Prior Authorization Added for LOQTORZI™

Holiday Closure

Our offices will be closed in observance of the Thanksgiving holiday on Thursday, Nov. 23 and Friday, Nov. 24. We will return to office, Monday, Nov. 27.

Prior Authorization Added for LOQTORZI™

Please note that BCBSWY requires authorization for LOQTORZI™ (toripalimab-tpzi). This is the first and only PD-1 inhibitor for the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma.

Medical Policy Reminder

As a reminder, be sure to check our Medical Policy for regular updates. Our Medical Policy can be found at BCBSWY.com/providers/policy/

Coding Advice, emergency protocol, medication authorizations

June 19, 2025

BCBSWY Humira Update

June 9, 2025

You’re Invited! To a Webinar Introducing: BCBSWY’s Maternity Care Program

May 23, 2025

Corrected Claims Update

May 12, 2025

L8699 Update

BCBSWY Newsroom

| June 19, 2025

BCBSWY Humira Update

Effective July 1, 2025, Hadlima, Simlandi, adalimumab-aaty, adalimumab-adaz will be the preferred biosimilar products on all BCBSWY formularies while Humira is being removed from…

| June 9, 2025

You’re Invited! To a Webinar Introducing: BCBSWY’s Maternity Care Program

Get ready for something exciting from Blue Cross Blue Shield of Wyoming! We’re thrilled to invite you to a special virtual launch event for…

| May 23, 2025

Corrected Claims Update

Effective July 1, 2025, Blue Cross Blue Shield of Wyoming (BCBSWY) will update the process for corrected bill claims. Corrected Bill Rules –…

Fewer Hassles. Better Service.

I am a...

I need to...

Who We Are

Helpful Links

We comply with applicable Federal civil rights laws and do not discriminate on the basis of race, color, national origin, age, disability, or sex, including sexual orientation, gender identity, or gender expression. We also provide language assistance. Read our Nondiscrimination and Language Assistance notice.

Prior Authorization Added for LOQTORZI™

Holiday Closure